Cellular Bioenergetics of Bone

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Primer on the metabolic bone diseases and disorders of mineral metabolism

• Publication date

  2018-09-28

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/9781119266594.CH129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Aging Reduces an ERRalpha‐Directed Mitochondrial Glutaminase Expression Suppressing Glutamine Anaplerosis and Osteogenic Differentiation of Mesenchymal Stem Cells

  2017cited by this paper
• In vivo radiometric analysis of glucose uptake and distribution in mouse bone

  2016cited by this paper
• Wnt Protein Signaling Reduces Nuclear Acetyl-CoA Levels to Suppress Gene Expression during Osteoblast Differentiation*

  2016cited by this paper
• HIF-1α Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival.

  2016cited by this paper
• The Warburg Effect: How Does it Benefit Cancer Cells?

  2016cited by this paper
• Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling

  2016cited by this paper
• Glucose Transporter-4 Facilitates Insulin-Stimulated Glucose Uptake in Osteoblasts.

  2016cited by this paper
• Alternative NF‐κB Regulates RANKL‐Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms

  2015cited by this paper
• Wnt-Lrp5 Signaling Regulates Fatty Acid Metabolism in the Osteoblast

  2015cited by this paper
• PTH Promotes Bone Anabolism by Stimulating Aerobic Glycolysis via IGF Signaling

  2015cited by this paper
• Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation.

  2015cited by this paper
• Increased glutamine catabolism mediates bone anabolism in response to WNT signaling.

  2015cited by this paper
• Mitochondrial complex I activity suppresses inflammation and enhances bone resorption by shifting macrophage-osteoclast polarization.

  2014cited by this paper
• Bioenergetics during calvarial osteoblast differentiation reflect strain differences in bone mass.

  2014cited by this paper
• Up-regulation of glycolytic metabolism is required for HIF1α-driven bone formation

  2014cited by this paper
• Aerobic Glycolysis in Osteoblasts

  2014cited by this paper
• Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit.

  2014cited by this paper
• Metabolic regulation of osteoclast differentiation and function

  2013cited by this paper
• WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation.

  2013cited by this paper
• Genetic Deletion of Catalytic Subunits of AMP-activated Protein Kinase Increases Osteoclasts and Reduces Bone Mass in Young Adult Mice*

  2013cited by this paper
• The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

  2012cited by this paper
• In situ metabolomic mass spectrometry imaging: recent advances and difficulties.

  2012cited by this paper
• Intracellular and Extracellular ATP Coordinately Regulate the Inverse Correlation between Osteoclast Survival and Bone Resorption*

  2012cited by this paper
• Dissecting Molecular Differences between Wnt Coreceptors LRP5 and LRP6

  2011cited by this paper
• Absence of Glutamine Supplementation Prevents Differentiation of Murine Calvarial Osteoblasts to a Mineralizing Phenotype

  2011cited by this paper
• Building strong bones: molecular regulation of the osteoblast lineage

  2011cited by this paper
• Stimulation of glucose transport in osteoblastic cells by parathyroid hormone and insulin-like growth factor I

  2011cited by this paper
• The protein family of glucose transport facilitators: It's not only about glucose after all

  2010cited by this paper
• O-GlcNAc signaling: a metabolic link between diabetes and cancer?

  2010cited by this paper
• Glutamine addiction: a new therapeutic target in cancer.

  2010cited by this paper
• Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease.

  2010cited by this paper
• Coordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation

  2009cited by this paper
• Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

  2009cited by this paper
• Bidirectional transport of amino acids regulates mTOR and autophagy.

  2009cited by this paper
• Osteoclast Precursors Display Dynamic Metabolic Shifts toward Accelerated Glucose Metabolism at an Early Stage of RANKL-Stimulated Osteoclast Differentiation

  2007cited by this paper
• Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

  2007cited by this paper
• Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.

  2005cited by this paper
• L-Carnitine and Isovaleryl L-Carnitine Fumarate Positively Affect Human Osteoblast Proliferation and Differentiation In Vitro

  2005cited by this paper
• The cellular fate of glucose and its relevance in type 2 diabetes.

  2004cited by this paper
• Glucose‐dependent regulation of osteoclast H+‐ATPase expression: Potential role of p38 MAP‐kinase

  2002cited by this paper
• Bioenergetics and mitochondrial transmembrane potential during differentiation of cultured osteoblasts.

  2000cited by this paper
• Carnitine and Dehydroepiandrosterone Sulfate Induce Protein Synthesis in Porcine Primary Osteoblast-Like Cells

  1999cited by this paper
• Glutamine, Exercise and Immune Function

  1998cited by this paper
• Regulation of osteoclastic bone resorption by glucose.

  1997cited by this paper
• Dexamethasone modulates insulin receptor expression and subcellular distribution of the glucose transporter GLUT 1 in UMR 106-01, a clonal osteogenic sarcoma cell line.

  1996cited by this paper
• Expression and regulation by insulin of GLUT 3 in UMR 106-01, a clonal rat osteosarcoma cell line.

  1996cited by this paper
• Osteoclastic bone resorption by a polarized vacuolar proton pump.

  1989cited by this paper
• Growth of rat osteoblast‐like cells in a lipid‐enriched culture medium and regulation of function by parathyroid hormone and 1,25‐dihydroxyvitamin D

  1988cited by this paper
• Fatty acid oxidation in bone tissue and bone cells in culture. Characterization and hormonal influences.

  1987cited by this paper
• Glutamine metabolism in bone.

  1983cited by this paper
• Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells.

  1979cited by this paper
• Parathyroid hormone stimulation of adenylate cyclase activity and lactic acid accumulation in calvaria of osteopetrotic (ia) rats.

  1978cited by this paper
• Aerobic glycolysis in bone: lactic acid production by rat calvaria cells in culture.

  1978cited by this paper
• Aerobic glycolysis in bone: lactate production and gradients in calvaria.

  1978cited by this paper
• METABOLIC STUDIES OF BONE IN VITRO. V. GLUCOSE METABOLISM AND COLLAGEN BIOSYNTHESIS.

  1964cited by this paper
• Bone Cells: Biochemical and Biological Studies after Enzymatic Isolation

  1964cited by this paper
• CELL POPULATION KINETICS OF AN OSTEOGENIC TISSUE {middle dot} II

  1963cited by this paper
• Glutamine metabolism in Ehrlich ascites-carcinoma cells.

  1962cited by this paper
• Aerobic metabolism of glucose by bone.

  1962cited by this paper
• Metabolic Studies of Bone in Vitro III. CITRIC ACID METABOLISM AND BONE MINERAL SOLUBILITY. EFFECTS OF PARATHYROID HORMONE AND ESTRADIOL

  1961cited by this paper
• Metabolic studies of bone in vitro. II. The metabolic patterns of accretion and resorption.

  1960cited by this paper
• [Origin of cancer cells].

  1956cited by this paper

• No citing papers are available for this paper.